Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. India
  4. Bombay Stock Exchange
  5. Aarti Drugs Limited
  6. SocietÓ
    524348   INE767A01016

AARTI DRUGS LIMITED

(524348)
RiassuntoGraficiNotizieRatingAgendaSocietÓFinanzaConsensusRevisioni 
AttivitÓ
Aarti Drugs Limited Ŕ una societÓ farmaceutica. L'azienda offre principi attivi farmaceutici (API) in una serie di categorie terapeutiche, quali antinfiammatori, cardioprotettivi, antifungini, antibiotici, antidiabetici, sedativi e vitamine. I suoi prodotti sotto APIs includono Aceclofenac, Diclofenac Potassio, Diclofenac Diethylamine, Clopidogrel Bisulphate e Telmisartan. I suoi intermedi farmaceutici comprendono Antiprotozoal, Celecoxib, Antibiotico, Clopidogrel, Diclofenac, Ketoconazolo, Nimesulide, Raloxifene, Zolpidem e Telmisartan. Offre anche prodotti chimici speciali, come il benzene solfonammide, l'estere metilico dell'acido benzensolfonico, il cloruro di benzene solfonilico, il nicotinato di metile, l'N-metilmetano solfonammide, l'Ortho para toluene solfonammide, l'Ortho/para toluene solfonil estere metilico dell'acido solfonico, il Para cloro benzensolfonammide, il Para toluene solfonil estere metilico dell'acido solfonico e il Para Toluene solfonil cloruro. Pinnacle Life Science Private Limited Ŕ la filiale della SocietÓ.

Numero di dipendenti : 3 285 persone.
Vendite per attivitÓ
20202021Delta
Pharmaceuticals Intermediary Products18 060.90100%21 547.80100% +19.31%
INR in Milioni
Vendite per regione
20202021Delta
India18 060.90100%21 547.80100% +19.31%
INR in Milioni
Dirigenti
Nome Titolo EtÓ Da
Prakash Moreshwar Patil Chairman, CEO & Managing Director 74 2015
Adhish P. Patil Chief Financial Officer 38 2012
Rushikesh Deole Secretary & Compliance Officer - 2019
Vilas Gajanan Gaikar, Dr. Independent Non-Executive Director 61 2011
Bhavesh Rasiklal Vora Independent Non-Executive Director 54 2011
Krishnacharya G. Akamanchi, Dr. Independent Non-Executive Director 68 2011
Navin Chapshi Shah Independent Non-Executive Director - 2010
Priti Pallavi Savla Independent Non-Executive Director 44 2014
Ankit Paleja Independent Director 37 2021
Harshit Manilal Savla Joint Managing Director & Executive Director 59 2012
Amministratori
Nome Titolo EtÓ Da
Prakash Moreshwar Patil Chairman, CEO & Managing Director 74 2015
Harit Pragji Shah Executive Director 58 2009
Chandrakant V. Gogri Chairman-Emeritus 75 2012
Uday Moreshwar Patil Executive Director 58 2000
Vilas Gajanan Gaikar, Dr. Independent Non-Executive Director 61 2011
Bhavesh Rasiklal Vora Independent Non-Executive Director 54 2011
Krishnacharya G. Akamanchi, Dr. Independent Non-Executive Director 68 2011
Navin Chapshi Shah Independent Non-Executive Director - 2010
Harshit Manilal Savla Joint Managing Director & Executive Director 59 2012
Rashesh Chandrakant Gogri Executive Director & Managing Director 47 2014
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 1 92 600 000 30 759 126 33.2% 0 0.0% 33.2%
Azionisti
NomeAzioni%
Prakash Moreshwar Patil 8 430 988 9,10%
Seema Harshit Savla 4 556 514 4,92%
Harshit Manilal Savla 4 376 733 4,73%
Rashesh Chandrakant Gogri 4 185 016 4,52%
Priti Prakash Patil 4 078 989 4,40%
Gogri Finserv Pvt Ltd. 3 518 025 3,80%
Hetal Gogri Gala 2 830 731 3,06%
Harit Pragji Shah 2 449 333 2,65%
Anushakti Enterprise Pvt Ltd. 2 430 032 2,62%
Mirik Rajendra Gogri 1 997 952 2,16%
Coordinate societÓ
Aarti Drugs Ltd.
Mahendra Industrial Estate
Road No. 29, Sion (East)
Plot No.109-D, Ground floor
Mumbai, Maharashtra 400022

Phone : +91.22.24019025
Fax : +91.22.24073462
Web : http://www.aartidrugs.co.in
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Aarti Drugs Limited
Settore Prodotti farmaceutici - Altri
Var. 1genCapi. (M$)
AARTI DRUGS LIMITED-8.45%618
JOHNSON & JOHNSON-4.73%429 034
ROCHE HOLDING AG-9.06%304 714
PFIZER, INC.-12.72%289 287
ABBVIE INC.-2.39%233 643
ELI LILLY AND COMPANY-12.00%217 963
NOVO NORDISK A/S-17.16%210 749
MERCK & CO., INC.2.86%199 120
NOVARTIS AG-4.40%187 626
ASTRAZENECA PLC-4.17%173 383
BRISTOL-MYERS SQUIBB COMPANY0.42%138 972
AMGEN INC.0.49%127 343
SANOFI-0.07%125 716
GLAXOSMITHKLINE PLC0.50%109 325
BAYER AG6.38%55 573
CHUGAI PHARMACEUTICAL CO., LTD-1.15%53 303
TAKEDA PHARMACEUTICAL COMPANY LIMITED6.47%45 679
DAIICHI SANKYO CO., LTD.-11.13%43 749
JIANGSU HENGRUI MEDICINE CO., LTD.-15.56%43 570
ASTELLAS PHARMA INC.2.94%31 326
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-19.40%19 699